TARS - Tarsus Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$95.67
DETAILS
HIGH:
$100.00
LOW:
$89.00
MEDIAN:
$98.00
CONSENSUS:
$95.67
UPSIDE:
33.32%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: TARS has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.